Category
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Today's News
More News
FORTE accrues first 1000 participants for highly anticipated colorectal cancer prevention trial

FORTE accrues first 1000 participants for highly anticipated colorectal cancer prevention trial

FORTE (NRG-CC005) is a highly anticipated colorectal cancer prevention trial led by NRG Oncology examining surveillance colonoscopy intervals in participants who have non-advanced polyps. Expected to

FORTE accrues first 1000 participants for highly anticipated colorectal cancer prevention trial

FORTE (NRG-CC005) is a highly anticipated colorectal cancer prevention trial led by NRG Oncology examining surveillance colonoscopy intervals in participants who have non-advanced polyps. Expected to
Preclinical research points to a promising new treatment option for pancreatic cancer patients

Preclinical research points to a promising new treatment option for pancreatic cancer patients

Preclinical research published in theJournal for ImmunoTherapy of Cancerpoints to a promising new treatment optionfor people with pancreatic cancer. Researchers from VCU Massey Compr

Preclinical research points to a promising new treatment option for pancreatic cancer patients

Preclinical research published in theJournal for ImmunoTherapy of Cancerpoints to a promising new treatment optionfor people with pancreatic cancer. Researchers from VCU Massey Compr
Novel microfluidic cell separation technology for early cancer detection

Novel microfluidic cell separation technology for early cancer detection

Early detection allows for timely intervention in many diseases before they progress to a severe stage, often at a lower treatment cost. This is particularly crucial in the case of cancer, as the stag

Novel microfluidic cell separation technology for early cancer detection

Early detection allows for timely intervention in many diseases before they progress to a severe stage, often at a lower treatment cost. This is particularly crucial in the case of cancer, as the stag
Can vitamins really fight cancer? New study uncovers surprising links between micronutrients and cancer risk

Can vitamins really fight cancer? New study uncovers surprising links between micronutrients and cancer risk

In a recent study published in the journalBMC Medicine,researchers evaluate the associations between micronutrients and cancer outcomes.Study:An atlas of associations between 14 micr

Can vitamins really fight cancer? New study uncovers surprising links between micronutrients and cancer risk

In a recent study published in the journalBMC Medicine,researchers evaluate the associations between micronutrients and cancer outcomes.Study:An atlas of associations between 14 micr
A comprehensive online resource allows for the exploration of interactions between mutational signatures and topographical features across human cancer

A comprehensive online resource allows for the exploration of interactions between mutational signatures and topographical features across human cancer

A study published in theCell ReportsJournal provides an online resource for studying the relationship between mutational signatures and topographical characteristics across human cancer.St

A comprehensive online resource allows for the exploration of interactions between mutational signatures and topographical features across human cancer

A study published in theCell ReportsJournal provides an online resource for studying the relationship between mutational signatures and topographical characteristics across human cancer.St
Study challenges the use of biochemical recurrence as prostate cancer predictor

Study challenges the use of biochemical recurrence as prostate cancer predictor

FINDINGSA UCLA-led study found treatments that reduce the risk of being diagnosed with a cancer recurrence based on rising prostate-specificantigen(PSA) levels after radiotherapy, commonly

Study challenges the use of biochemical recurrence as prostate cancer predictor

FINDINGSA UCLA-led study found treatments that reduce the risk of being diagnosed with a cancer recurrence based on rising prostate-specificantigen(PSA) levels after radiotherapy, commonly
Innovative insights into effects of hematopoietic changes on colon cancer, unveiling therapeutic avenues

Innovative insights into effects of hematopoietic changes on colon cancer, unveiling therapeutic avenues

In a recent study published in theJournal of Experimental Medicine, researchers investigated whether bone marrow-derived cells with heterozygous loss of Dnmt3a (Dnmt3a+/Δ), the most common genet

Innovative insights into effects of hematopoietic changes on colon cancer, unveiling therapeutic avenues

In a recent study published in theJournal of Experimental Medicine, researchers investigated whether bone marrow-derived cells with heterozygous loss of Dnmt3a (Dnmt3a+/Δ), the most common genet
Is obesity associated with risk of head and neck cancer?

Is obesity associated with risk of head and neck cancer?

In a recent study published inBMC Medical Genomics, researchers assessed the association between obesity and head and neck cancer risk.Study:Obesity and head and neck cancer risk: a mendel

Is obesity associated with risk of head and neck cancer?

In a recent study published inBMC Medical Genomics, researchers assessed the association between obesity and head and neck cancer risk.Study:Obesity and head and neck cancer risk: a mendel
Analysis reveals limited evidence on use of cannabis products in children with cancer

Analysis reveals limited evidence on use of cannabis products in children with cancer

A recent analysis of all relevant published studies reveals a lack of evidence to determine the dosing, safety, andefficacy ofmedical marijuana or cannabis-containing products for managing

Analysis reveals limited evidence on use of cannabis products in children with cancer

A recent analysis of all relevant published studies reveals a lack of evidence to determine the dosing, safety, andefficacy ofmedical marijuana or cannabis-containing products for managing
Longer duration of anticoagulation therapy benefits cancer patients with isolated distal DVT

Longer duration of anticoagulation therapy benefits cancer patients with isolated distal DVT

Twelve months of edoxaban is superior to three months for the reduction of thrombotic events in patients with cancer and distaldeep vein thrombosis(DVT), according to late breaking researc

Longer duration of anticoagulation therapy benefits cancer patients with isolated distal DVT

Twelve months of edoxaban is superior to three months for the reduction of thrombotic events in patients with cancer and distaldeep vein thrombosis(DVT), according to late breaking researc
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...